Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gioia M. Guerrieri"'
Autor:
Peter Schmidt, Xiaobai Li, David R. Rubinow, Lynnette K Neiman, Rivka Ben Dor, Shau-Ming Wei, Gioia M Guerrieri, Pedro E. Martinez
Publikováno v:
J Clin Endocrinol Metab
Context Abnormalities in the hypothalamic-pituitary-adrenal (HPA) axis are frequent accompaniments of depression, and studies have documented the role of stress and stressful life events in the ontogeny of perimenopausal depressions (PMD). Because HP
Autor:
Constance Zou, Rivka Ben Dor, Gioia M. Guerrieri, Pedro Martinez, Peggy McCluggage, Lynnette Nieman, Paul Walkim, David Rubinow, Peter Schmidt
Publikováno v:
Biological Psychiatry. 93:S113
Autor:
Howard J. Li, Paula P Palladino, Lynnette K. Nieman, Veronica L Harsh, Pedro E. Martinez, Gioia M Guerrieri, Rivka Ben Dor, Paul Wakim, Shau-Ming Wei, David R. Rubinow, Peter J. Schmidt
Publikováno v:
Menopause
Objective We examined the short-term efficacies of three estrogen-like compounds under placebo-controlled conditions in women with perimenopause-related depression (PMD). Methods Women with PMD were randomized in a double-blind parallel design to one
Autor:
Amber B. Courville, Pedro E. Martinez, Michael Glicksman, Justin A. Rodante, Shanna B. Yang, Jay H. Chung, Sung-Jun Park, Hongyi Cai, Ronald Ouwerkerk, Sandra D. MacDonald, Rivka R Ben-Dor, Ijeoma M. Muo, Peter Walter, Mary Walter, Gioia M. Guerrieri, Ahmed M. Gharib, Stephanie Mao, Ritu Madan
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Purpose Roflumilast (Daliresp, Daxas) is a FDA-approved phosphodiesterase 4 (PDE4) inhibitor for the treatment of moderate-to-severe chronic obstructive pulmonary disease. In mice and in limited human studies, this oral medication can cause weight lo
Autor:
Ella J. Hong, Nazli Haq, Pedro E. Martinez, Paul Wakim, Gioia M. Guerrieri, Lynnette K. Nieman, Peter Schmidt, David R. Rubinow, Rivka Ben Dor
Publikováno v:
Biological Psychiatry. 87:S159
Autor:
Rivka Ben Dor, Pedro E. Martinez, David R. Rubinow, Peter Schmidt, Gioia M. Guerrieri, Lynnette K. Nieman, Karla Thompson, Deloris E. Koziol, Veronica L. Harsh
Publikováno v:
JAMA Psychiatry. 72:714
IMPORTANCE: Perimenopause is accompanied by an increased risk of new and recurrent depression. The coincidence of declining ovarian function with the onset of depression led to the inference that "withdrawal" from physiologic estradiol levels underpi